NCT01632657View on ClinicalTrials.gov

Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 15, 2019

Study Completion Date

December 15, 2019

Conditions
Postoperative Quality of RecoveryPostoperative Migrainous Headache
Interventions
DRUG

Sumatriptan

Single subcutaneous injection sumatriptan 6mg (in 0.5ml) in recovery

OTHER

Placebo

Single injection saline 0.5ml subcutaneously in recovery

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01632657 - Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy | Biotech Hunter | Biotech Hunter